特邀评论——世界卫生组织肿瘤分类：肿瘤应如何分类？专家共识、系统评价还是两者皆用？ - Suppr

Suppr

超能文献

Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both?

作者信息

Uttley Lesley, Indave Blanca Iciar, Hyde Chris, White Valerie, Lokuhetty Dilani, Cree Ian

机构信息

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

World Health Organization, Classification of Tumours Group, International Agency for Research on Cancer, Lyon, France.

出版信息

Int J Cancer. 2020 Jun 15;146(12):3516-3521. doi: 10.1002/ijc.32975. Epub 2020 Apr 2.

DOI:10.1002/ijc.32975

PMID:32170735

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7818407/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fda/7818407/b0c04344388f/IJC-146-3516-g001.jpg

相似文献

Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both?

Int J Cancer. 2020 Jun 15;146(12):3516-3521. doi: 10.1002/ijc.32975. Epub 2020 Apr 2.

A new series of Invited Reviews on WHO tumor classification.

Int J Cancer. 2020 Jun 15;146(12):3243. doi: 10.1002/ijc.32983. Epub 2020 Apr 2.

[Standards, Options and Recommendations: a multidisciplinary program to promote evidence-based oncology].

Bull Cancer. 2001 Jun;88(6):601-4.

Delivering consensus from the Asian Oncology Summit 2009.

Lancet Oncol. 2009 Nov;10(11):1029-30. doi: 10.1016/S1470-2045(09)70324-9.

Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.

Cancer Treat Rev. 2005 Jun;31(4):319-22. doi: 10.1016/j.ctrv.2005.04.001.

ESMO clinical recommendations: a practical guide for medical oncologists.

Ann Oncol. 2007 Nov;18(11):1759-63. doi: 10.1093/annonc/mdm362. Epub 2007 Oct 5.

Guidance on the creation of evidence-linked guidelines for COIN.

Clin Oncol (R Coll Radiol). 1999;11(1):28-32. doi: 10.1053/clon.1999.9005.

[Foreward].

Onkologie. 2013;36 Suppl 2:1. doi: 10.1159/000348561.

COVID-19 and cancer: do we really know what we think we know?

Nat Rev Clin Oncol. 2020 Jul;17(7):386-388. doi: 10.1038/s41571-020-0394-y.

Response evaluation criteria in solid tumors (RECIST): new guidelines.

Med Pediatr Oncol. 2001 Jul;37(1):1-3. doi: 10.1002/mpo.1154.

引用本文的文献

Preferred labels and language to improve communication about lesions at low risk of progressing to cancer: qualitative interviews with patients and physicians.

BMJ Open. 2025 Jan 2;15(1):e087484. doi: 10.1136/bmjopen-2024-087484.

Mesenchymal Stem Cells in Myelodysplastic Syndromes and Leukaemia.

Biomedicines. 2024 Jul 26;12(8):1677. doi: 10.3390/biomedicines12081677.

Exploring the Genomic Landscape of Hepatobiliary Cancers to Establish a Novel Molecular Classification System.

Cancers (Basel). 2024 Jan 11;16(2):325. doi: 10.3390/cancers16020325.

Seeing the random forest through the decision trees. Supporting learning health systems from histopathology with machine learning models: Challenges and opportunities.

J Pathol Inform. 2023 Nov 4;15:100347. doi: 10.1016/j.jpi.2023.100347. eCollection 2024 Dec.

Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia.

Int J Mol Sci. 2023 May 15;24(10):8764. doi: 10.3390/ijms24108764.

Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022).

Eur J Med Chem. 2023 Aug 5;256:115476. doi: 10.1016/j.ejmech.2023.115476. Epub 2023 May 13.

Lack of systematicity in research prioritisation processes - a scoping review of evidence syntheses.

Syst Rev. 2022 Dec 23;11(1):277. doi: 10.1186/s13643-022-02149-2.

Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung.

BMJ Open. 2022 Oct 11;12(10):e061240. doi: 10.1136/bmjopen-2022-061240.

Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?

Mod Pathol. 2022 Oct;35(10):1484-1493. doi: 10.1038/s41379-022-01100-z. Epub 2022 Jul 23.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

本文引用的文献

Time to challenge the spurious hierarchy of systematic over narrative reviews?

Eur J Clin Invest. 2018 Jun;48(6):e12931. doi: 10.1111/eci.12931. Epub 2018 Apr 16.

The influence of the team in conducting a systematic review.

Syst Rev. 2017 Aug 1;6(1):149. doi: 10.1186/s13643-017-0548-x.

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

BMJ Open. 2016 Nov 14;6(11):e012799. doi: 10.1136/bmjopen-2016-012799.

What are the best methodologies for rapid reviews of the research evidence for evidence-informed decision making in health policy and practice: a rapid review.

Health Res Policy Syst. 2016 Nov 25;14(1):83. doi: 10.1186/s12961-016-0155-7.

The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.

Milbank Q. 2016 Sep;94(3):485-514. doi: 10.1111/1468-0009.12210.

Reviewing the literature, how systematic is systematic?

Int J Clin Pharm. 2016 Jun;38(3):685-94. doi: 10.1007/s11096-016-0288-3. Epub 2016 Apr 5.

Rapid Review Summit: an overview and initiation of a research agenda.

Syst Rev. 2015 Sep 26;4:111. doi: 10.1186/s13643-015-0111-6.

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.

Consensus development for healthcare professionals.

Intern Emerg Med. 2015 Apr;10(3):373-83. doi: 10.1007/s11739-014-1156-6. Epub 2014 Nov 28.

Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?

BMJ. 2012 Nov 1;345:e7031. doi: 10.1136/bmj.e7031.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both?

作者信息

Uttley Lesley, Indave Blanca Iciar, Hyde Chris, White Valerie, Lokuhetty Dilani, Cree Ian

机构信息

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

World Health Organization, Classification of Tumours Group, International Agency for Research on Cancer, Lyon, France.

出版信息

Int J Cancer. 2020 Jun 15;146(12):3516-3521. doi: 10.1002/ijc.32975. Epub 2020 Apr 2.

DOI:10.1002/ijc.32975

PMID:32170735

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7818407/

Abstract

摘要

相似文献

Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both?

Int J Cancer. 2020 Jun 15;146(12):3516-3521. doi: 10.1002/ijc.32975. Epub 2020 Apr 2.

A new series of Invited Reviews on WHO tumor classification.

Int J Cancer. 2020 Jun 15;146(12):3243. doi: 10.1002/ijc.32983. Epub 2020 Apr 2.

[Standards, Options and Recommendations: a multidisciplinary program to promote evidence-based oncology].

Bull Cancer. 2001 Jun;88(6):601-4.

Delivering consensus from the Asian Oncology Summit 2009.

Lancet Oncol. 2009 Nov;10(11):1029-30. doi: 10.1016/S1470-2045(09)70324-9.

Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.

Cancer Treat Rev. 2005 Jun;31(4):319-22. doi: 10.1016/j.ctrv.2005.04.001.

ESMO clinical recommendations: a practical guide for medical oncologists.

Ann Oncol. 2007 Nov;18(11):1759-63. doi: 10.1093/annonc/mdm362. Epub 2007 Oct 5.

Guidance on the creation of evidence-linked guidelines for COIN.

Clin Oncol (R Coll Radiol). 1999;11(1):28-32. doi: 10.1053/clon.1999.9005.

[Foreward].

Onkologie. 2013;36 Suppl 2:1. doi: 10.1159/000348561.

COVID-19 and cancer: do we really know what we think we know?

Nat Rev Clin Oncol. 2020 Jul;17(7):386-388. doi: 10.1038/s41571-020-0394-y.

Response evaluation criteria in solid tumors (RECIST): new guidelines.

Med Pediatr Oncol. 2001 Jul;37(1):1-3. doi: 10.1002/mpo.1154.

引用本文的文献

Preferred labels and language to improve communication about lesions at low risk of progressing to cancer: qualitative interviews with patients and physicians.

BMJ Open. 2025 Jan 2;15(1):e087484. doi: 10.1136/bmjopen-2024-087484.

Mesenchymal Stem Cells in Myelodysplastic Syndromes and Leukaemia.

Biomedicines. 2024 Jul 26;12(8):1677. doi: 10.3390/biomedicines12081677.

Exploring the Genomic Landscape of Hepatobiliary Cancers to Establish a Novel Molecular Classification System.

Cancers (Basel). 2024 Jan 11;16(2):325. doi: 10.3390/cancers16020325.

Seeing the random forest through the decision trees. Supporting learning health systems from histopathology with machine learning models: Challenges and opportunities.

J Pathol Inform. 2023 Nov 4;15:100347. doi: 10.1016/j.jpi.2023.100347. eCollection 2024 Dec.

Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia.

Int J Mol Sci. 2023 May 15;24(10):8764. doi: 10.3390/ijms24108764.

Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022).

Eur J Med Chem. 2023 Aug 5;256:115476. doi: 10.1016/j.ejmech.2023.115476. Epub 2023 May 13.

Lack of systematicity in research prioritisation processes - a scoping review of evidence syntheses.

Syst Rev. 2022 Dec 23;11(1):277. doi: 10.1186/s13643-022-02149-2.

Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung.

BMJ Open. 2022 Oct 11;12(10):e061240. doi: 10.1136/bmjopen-2022-061240.

Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?

Mod Pathol. 2022 Oct;35(10):1484-1493. doi: 10.1038/s41379-022-01100-z. Epub 2022 Jul 23.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

本文引用的文献

Time to challenge the spurious hierarchy of systematic over narrative reviews?

Eur J Clin Invest. 2018 Jun;48(6):e12931. doi: 10.1111/eci.12931. Epub 2018 Apr 16.

The influence of the team in conducting a systematic review.

Syst Rev. 2017 Aug 1;6(1):149. doi: 10.1186/s13643-017-0548-x.

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

BMJ Open. 2016 Nov 14;6(11):e012799. doi: 10.1136/bmjopen-2016-012799.

What are the best methodologies for rapid reviews of the research evidence for evidence-informed decision making in health policy and practice: a rapid review.

Health Res Policy Syst. 2016 Nov 25;14(1):83. doi: 10.1186/s12961-016-0155-7.

The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.

Milbank Q. 2016 Sep;94(3):485-514. doi: 10.1111/1468-0009.12210.

Reviewing the literature, how systematic is systematic?

Int J Clin Pharm. 2016 Jun;38(3):685-94. doi: 10.1007/s11096-016-0288-3. Epub 2016 Apr 5.

Rapid Review Summit: an overview and initiation of a research agenda.

Syst Rev. 2015 Sep 26;4:111. doi: 10.1186/s13643-015-0111-6.

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.

Consensus development for healthcare professionals.

Intern Emerg Med. 2015 Apr;10(3):373-83. doi: 10.1007/s11739-014-1156-6. Epub 2014 Nov 28.

Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?

BMJ. 2012 Nov 1;345:e7031. doi: 10.1136/bmj.e7031.